Search research articles
Contact Us
Filters
Showing results (861-870 of 962) with videos related to
Page
of 97
Sort By:
Thrombosis and Haemostasis
|
August 1, 2019
Geographical Variations in Patterns of DAPT Cessation and Two-Year PCI Outcomes: Insights from the PARIS Registry
Birgit Vogel, Jaya Chandrasekhar, Usman Baber, et al.
American Heart Journal
|
November 23, 2022
Rationale and design for the myocardial ischemia and transfusion (MINT) randomized clinical trial
Jeffrey L Carson, Maria Mori Brooks, Bernard R Chaitman, et al.
JAMA
|
September 1, 2014
Effect of darapladib on major coronary events after an acute coronary syndrome: the SOLID-TIMI 52 randomized clinical trial
Michelle L O'Donoghue, Eugene Braunwald, Harvey D White, et al.
Archives of Cardiovascular Diseases
|
February 9, 2025
Machine learning to detect recent recreational drug use in intensive cardiac care units
Nathan El Bèze, Kenza Hamzi, Patrick Henry, et al.
NEJM Evidence
|
December 23, 2024
Restrictive versus Liberal Transfusion in Myocardial Infarction - A Patient-Level Meta-Analysis
Jeffrey L Carson, Dean A Fergusson, Helaine Noveck, et al.
Heart (British Cardiac Society)
|
August 15, 2023
Prevalence and impact of recreational drug use in patients with acute cardiovascular events
Théo Pezel, Jean-Guillaume Dillinger, Antonin Trimaille, et al.
Journal of the American College of Cardiology
|
January 18, 2020
Effect of Alirocumab on Lipoprotein(a) and Cardiovascular Risk After Acute Coronary Syndrome
Vera A Bittner, Michael Szarek, Philip E Aylward, et al.
The Lancet. Public Health
|
September 20, 2020
Hospital admissions for acute myocardial infarction before and after lockdown according to regional prevalence of COVID-19 and patient profile in France: a registry study
Jules Mesnier, Yves Cottin, Pierre Coste, et al.
Circulation
|
November 2, 2022
The Effects of Angiotensin Receptor-Neprilysin Inhibition on Major Coronary Events in Patients With Acute Myocardial Infarction: Insights From the PARADISE-MI Trial
Roxana Mehran, Philippe Gabriel Steg, Marc A Pfeffer, et al.
Journal of the American College of Cardiology
|
November 15, 2018
Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events: The ODYSSEY OUTCOMES Trial
Michael Szarek, Harvey D White, Gregory G Schwartz, et al.
Page
of 97
Search research articles
Search
Showing results (861-870 of 962) with videos related to
Sort By:
Page
of 97
Thrombosis and Haemostasis
|
August 1, 2019
Geographical Variations in Patterns of DAPT Cessation and Two-Year PCI Outcomes: Insights from the PARIS Registry
Birgit Vogel, Jaya Chandrasekhar, Usman Baber, et al.
American Heart Journal
|
November 23, 2022
Rationale and design for the myocardial ischemia and transfusion (MINT) randomized clinical trial
Jeffrey L Carson, Maria Mori Brooks, Bernard R Chaitman, et al.
JAMA
|
September 1, 2014
Effect of darapladib on major coronary events after an acute coronary syndrome: the SOLID-TIMI 52 randomized clinical trial
Michelle L O'Donoghue, Eugene Braunwald, Harvey D White, et al.
Archives of Cardiovascular Diseases
|
February 9, 2025
Machine learning to detect recent recreational drug use in intensive cardiac care units
Nathan El Bèze, Kenza Hamzi, Patrick Henry, et al.
NEJM Evidence
|
December 23, 2024
Restrictive versus Liberal Transfusion in Myocardial Infarction - A Patient-Level Meta-Analysis
Jeffrey L Carson, Dean A Fergusson, Helaine Noveck, et al.
Heart (British Cardiac Society)
|
August 15, 2023
Prevalence and impact of recreational drug use in patients with acute cardiovascular events
Théo Pezel, Jean-Guillaume Dillinger, Antonin Trimaille, et al.
Journal of the American College of Cardiology
|
January 18, 2020
Effect of Alirocumab on Lipoprotein(a) and Cardiovascular Risk After Acute Coronary Syndrome
Vera A Bittner, Michael Szarek, Philip E Aylward, et al.
The Lancet. Public Health
|
September 20, 2020
Hospital admissions for acute myocardial infarction before and after lockdown according to regional prevalence of COVID-19 and patient profile in France: a registry study
Jules Mesnier, Yves Cottin, Pierre Coste, et al.
Circulation
|
November 2, 2022
The Effects of Angiotensin Receptor-Neprilysin Inhibition on Major Coronary Events in Patients With Acute Myocardial Infarction: Insights From the PARADISE-MI Trial
Roxana Mehran, Philippe Gabriel Steg, Marc A Pfeffer, et al.
Journal of the American College of Cardiology
|
November 15, 2018
Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events: The ODYSSEY OUTCOMES Trial
Michael Szarek, Harvey D White, Gregory G Schwartz, et al.
Page
of 97